Clinical manifestations and course of meningococcal disease in 562 patients

Scandinavian Journal of Infectious Diseases

Volumn 28, Issue 1, 1996, Pages 47-51

  Schildkamp, Regina L ^a   Lodder, Mariette C ^c   Bijlmer, Henk A ^b   Dankert, Jacob ^a   Scholten, Rob J P M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b MEDICAL CENTER HAAGLANDEN   (Netherlands)

^c Univ Amsterdam/Natl Inst Pub H ^*

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BACTEREMIA; BACTERIUM CULTURE; CHILD; CLINICAL FEATURE; COMA; DISABILITY; DISEASE COURSE; DISEASE PREDISPOSITION; FAMILY HISTORY; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MENINGITIS; MENINGOCOCCOSIS; MORTALITY; NETHERLANDS; NEWBORN; PETECHIA; QUESTIONNAIRE; RECURRENT DISEASE; SEIZURE;

EID: 0029923037     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365549609027149     Document Type: Article

References (20)

1. Netherlands Reference Laboratory for Bacterial Meningitis. Bacterial meningitis in the Netherlands; annual reports 1980-1992. Amsterdam: Universiteit van Amsterdam, 1981-1993.
2. Peltola H. Meningococcal disease: still with us. Rev Infect Dis 5: 71-91, 1983.
3. Schwartz B, Moore PS, Broome CV. Global epidemiology of meningococcal disease. Clin Microbiol Rev 2 (Suppl): S118-S124, 1989.
4. Baraff LJ, Lee SI, Schriger DL Outcomes of bacterial meningitis in children: a meta-analysis. Pediatr Infect Dis J 12: 389-394, 1993.
5. Havens PL, Garland JS, Brook MM, Dewitz BA, Stremski ES, Troshynski TJ. Trends in mortality in children hospitalized with meningococcal infections, 1957 to 1987. Pediatr Infect Dis J 8: 8-11, 1989.
6. Scholten RJPM, Bijlmer HA, Poolman JT, Kuipers B, Caugant DA, Van Alphen AJW, Dankert J, Valkenburg HA. Meningococcal disease in the Netherlands, 1958-1990. A steady increase in the incidence since 1982 partially caused by new serotypes and subtypes of Neisseria meningitidis. Clin Infect Dis 16: 237-246, 1993.
7. Scholten RJPM, Bijlmer HA, Valkenburg HA, Dankert J. Patient and strain characteristics in relation to the outcome of meningococcal disease: a multivariate analysis. Epidemiol Infect 112: 115-124, 1994.
8. Scholten RJPM, Kuipers B, Valkenburg HA, Dankert J, Zollinger WD, Poolman JT. Lipo-oligosaccharide immunotyping of Neisseria meningitidis by a whole-cell ELISA with monoclonal antibodies. J Med Microbiol 41: 236-243, 1994.
9. Spanjaard L, Bol P, Ekker W, Zanen HC. The incidence of bacterial meningitis in the Netherlands: a comparison of three registration systems, 1977-1982. J Infect 11: 259-268, 1985.
10. Goldschneider I, Gotschlich EC, Artenstein RS. Human immunity to the meningococcus. II. Development of natural immunitiy. J Exp Med 129: 1327-1348, 1969.
11. Bohr V, Hansen B, Jessen O, Johnsen N, Kjersem H, Kristensen HS, Nyboe J, Rasmussen N. Eight hundred and seventy-five cases of bacterial meningitis. Part I of a three-part series: Clinical data, prognosis, and the role of specialised hospital departments. J Infect 7: 21-30, 1983.
12. Swart AG, Fijen CAP, Te Bulte MT, Daha MR, Dankert J, Kuijper EJ. Complement deficienties en meningokokkenziekte in Nederland. Ned Tijdschr Geneeskd 137: 1147-1152, 1993.
13. Anonymous. Drugs for the doctor's bag Drug Ther Bull 27: 17-19, 1989.
14. Halstensen A, Pedersen SHJ, Haneberg B, Bjorvatn B, Solberg CO. Case fatality of meningococcal disease m Western Norway. Scand J Infect Dis 19: 35-42, 1987.
15. Borchsenius F, Bruun JN, Tønjum T. Systemic meningococcal disease: the diagnosis on admission to hospital. NIPH Ann 14: 11-22, 1991.
16. Spanjaard L, Bol P, De Mane S, Zanen HC. Association of meningococcal serogroups with the course of disease in the Netherlands, 1959-83. Bull WHO 65: 861-868, 1987.
17. Palmer SR, Corson J, Hall R, Payne S, Ludlow J, Deere B, Jones H, Kaul S, Stubbins J, Williams R, Walapu M, Spence A, Jenkins P, Donald D. Meningococcal disease in Wales: clinical features, outcome and public health management. J Infect 25: 321-328, 1992.
18. Samuelsson S, Ege P, Berthelsen B, Lind I. An outbreak of serogroup B:15:P1.16 meningococcal disease, Frederiksborg County, Denmark, 1987-9. Epidemiol Infect 108: 19-30, 1992.
19. Tüysüz B, Özlü I, Aji DY, Erginel A. Prognostic factors in meningococcal disease and a new scoring system. Acta Pediatr Scand 82: 1053-1056, 1993.
20. Naess A, Halstensen A, Nyland H, Pedersen SHJ, Møller P, Borgmann R, Larsen JL, Haga E. Sequelae one year after meningococcal disease. Acta Neurol Scand 89: 139-142, 1994.